Paediatric Surgery (Ukraine). 2024. 4(85): 31-42. doi: 10.15574/PS.2024.4(85).3142
Bilyayeva O. O.¹, Karol I. V.², Dyadyk O. O.^1
1Shupyk National Healthcare University of Ukraine, Kyiv
²Odesa Regional Clinical Hospital, Ukraine

For citation: Bilyayeva OO, Karol IV, Dyadyk OO. (2024). Probiotic disinfectants in the complex treatment of experimental peritonitis. Paediatric Surgery (Ukraine). 4(85): 31-42. doi: 10.15574/PS.2024.4(85).3142.
Article received: Aug 19, 2024. Accepted for publication: Dec 10, 2024.

Aim – to investigate the effectiveness of probiotic disinfectants in the complex treatment of experimental peritonitis.
Materials and methods. The experimental study was performed on 45 white sexually mature rats, which were simulated with fecal peritonitis. The rats were divided into 3 groups of 15 animals. The treatment of rats in the group I (main) consisted of washing the abdominal cavity with a 5% solution of probiotic disinfectant, applying a probiotic disinfectant spray to the abdominal organs and a gel with probiotics to the surgical wound after its suturing. For the treatment of rats in thr group II (comparison group), a sorbent solution was used to wash the abdominal cavity. The treatment of rats in the group III (placebo control) consisted of washing the abdominal cavity with 0.9% NaCl. The content of medium-weight molecules (total), the toxin-binding capacity of serum proteins, and the functional activity of monocytes in the general NST test were studied. A pathomorphological study was also conducted.
Results. The use of the developed treatment in the experiment in animals of the group I contributed to a decrease in the content of medium-weight molecules and the restoration of the toxin-binding capacity of albumin already on the 5th day. These trends cause a decrease in the cytolytic activity of blood serum relative to its own leukocytes and the preservation of the functional capabilities of monocytes at an adapted level already on the 5th day. At the same time, on the 7th day, the indicators of the functional activity of monocytes corresponded to the reference values. In animals of the group II, the optimization of the studied indicators occurred only on the 7th day, but they did not correspond to the reference values. In the group III, the studied indicators were significantly reduced relative to the reference values throughout the study.
Conclusions. The results of the study demonstrate the effectiveness of using probiotic disinfectants for the sanitation of the abdominal cavity in animals with fecal peritonitis.
The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of all participating institution. When carrying out experiments with laboratory animals, all bioethical norms and recommendations were observed.
No conflict of interest was declared by the authors.
Keywords: peritonitis, endogenous intoxication, multiple organ failure, probiotics.

REFERENCES

1. Abriouel H, Franz CM, Omar NB, Gálvez A. (2011). Diversity and applications of Bacillus bacteriocins. FEMS Microbiol. Rev. 35(1): 201-232. https://doi.org/10.1111/j.1574-6976.2010.00244.x; PMid:20695901

2. Alessandrini G, Mercuri SR, Martella A, Ferrara F, Simonetti V et al. (2023). Topical application of bacteriocins from Bacillus subtilis promotes Staphylococcus aureus decolonization in acneic skin and improves the clinical appearance of mild-to-moderate acne. Postepy Dermatol Alergol. 40(1): 115-118. https://doi.org/10.5114/ada.2022.124108; PMid:36909897 PMCid:PMC9993192

3. Al-Marzooq F, Bayat SA, Sayyar F, Ishaq H, Nasralla H et al. (2018). Can probiotic cleaning solutions replace chemical disinfectants in dental clinics? Eur J Dent. 12(4): 532-539. https://doi.org/10.4103/ejd.ejd_124_18; PMid:30369799 PMCid:PMC6178676

4. Andreichyn MA, Bekh MD, Demianenko VV, Nychyk AZ, Nychyk NA. (1998). Metody doslidzhennia endohennoi intoksykatsii orhanizmu: metodychni rekomendatsii. Kyiv: MOZ Ukrainy: 31.

5. Bassi A, Sharma G, Deol PK, Madempudi RS, Kaur IP. (2023). Preclinical Potential of Probiotic-Loaded Novel Gelatin-Oil Vaginal Suppositories: Efficacy, Stability, and Safety Studies. Gels. 9(3): 244. https://doi.org/10.3390/gels9030244; PMid:36975693 PMCid:PMC10048646

6. Bekiaridou A, Karlafti E, Oikonomou IM, Ioannidis A, Papavramidis TS. (2021). Probiotics and Their Effect on Surgical Wound Healing: A Systematic Review and New Insights into the Role of Nanotechnology. Nutrients. 13(12): 4265. https://doi.org/10.3390/nu13124265; PMid:34959817 PMCid:PMC8704946

7. Bhat M, Arendt BM, Bhat V, Renner EL, Humar A, Allard JP. (2016). Implication of the intestinal microbiome in complications of cirrhosis. World J Hepatol. 8(27): 1128-1136. https://doi.org/10.4254/wjh.v8.i27.1128; PMid:27721918 PMCid:PMC5037326

8. Biliaieva OO, Karol IV, Kryzhevskyi VV, Osadcha OI. (2024). Dynamika pokaznykiv oksydantno-antyoksydantnykh reaktsii u pisliaoperatsiinomu periodi u khvorykh na poshyrenyi perytonit. Khirurhiia dytiachoho viku (Ukraina). 1(82): 18-26. https://doi.org/10.15574/PS.2024.82.18

9. Biliaieva OO, Kryzhevskyi VV, Karol IV. (2021). Prychyny nezadovilnykh rezultativ diahnostyky perytonitu na dohospitalnomu etapi. Ukrainskyi medychnyi chasopys. 4(144): 1-4. https://doi.org/10.32471/umj.1680-3051.144.214004

10. Biliaieva OO, Kryzhevskyi VV, Karol IV. (2023). Obgruntuvannia zastosuvannia enterosorbtsii u khvorykh na perytonit v toksychnii ta terminalnii stadiiakh. Ukrainskyi medychnyi chasopys. 2(154): 3-6. https://doi.org/10.32471/umj.1680-3051.154.241849

11. Caselli E, Arnoldo L, Rognoni C, D'Accolti M, Soffritti I, Lanzoni L et al. (2019). Impact of a probiotic-based hospital sanitation on antimicrobial resistance and HAI-associated antimicrobial consumption and costs: a multicenter study. Infection and Drug Resistance. 12: 501-510. https://doi.org/10.2147/IDR.S194670; PMid:30881055 PMCid:PMC6398408

12. Caselli E, D'Accolti M, Vandini A, Lanzoni L, Camerada MT, Coccagna M et al. (2016). Impact of a Probiotic-Based Cleaning Intervention on the Microbiota Ecosystem of the Hospital Surfaces: Focus on the Resistome Remodulation. PLoS One. 11(2): e0148857. https://doi.org/10.1371/journal.pone.0148857; PMid:26886448 PMCid:PMC4757022

13. Caulier S, Nannan C, Gillis A, Licciardi F, Bragard C, Mahillon J. (2019). Overview of the Antimicrobial Compounds Produced by Members of the Bacillus subtilis Group. Front. Microbiol. 10: 302. https://doi.org/10.3389/fmicb.2019.00302; PMid:30873135 PMCid:PMC6401651

14. D'Accolti M, Soffritti I, Bonfante F, Ricciardi W, Mazzacane S, Caselli E. (2021). Potential of an Eco-Sustainable Probiotic-Cleaning Formulation in Reducing Infectivity of Enveloped Viruses. Viruses. 13(11): 2227. https://doi.org/10.3390/v13112227; PMid:34835033 PMCid:PMC8617880

15. D'Accolti M, Soffritti I, Mazzacane S, Caselli E. (2019). Fighting AMR in the Healthcare Environment: Microbiome-Based Sanitation Approaches and Monitoring Tools. Int J Mol Sci. 20(7): 1535. https://doi.org/10.3390/ijms20071535; PMid:30934725 PMCid:PMC6479322

16. Dashti N, Zarebavani M. (2021). Probiotics in the management of Giardia duodenalis: an update on potential mechanisms and outcomes. Naunyn Schmiedebergs Arch Pharmacol. 394(9): 1869-1878. https://doi.org/10.1007/s00210-021-02124-z; PMid:34324017

17. Dmytryk VV, Krenytska DI, Luhovska TV, Yakovlev PH. (2018). Kilkisnyi ta yakisnyi sklad molekul serednoi masy v plazmi krovi ta homohenatakh pukhlyn v khvorykh na rak sechovoho mikhura. Scientific Journal «ScienceRise: Biological Science». 5(14): 41-46. https://doi.org/10.15587/2519-8025.2018.148330

18. Dussert E, Tourret M, Dupuis C, Noblecourt A, Behra-Miellet J, Flahaut C et al. (2022). Evaluation of Antiradical and Antioxidant Activities of Lipopeptides Produced by Bacillus subtilis Strains. Front. Microbiol. 13: 914713. https://doi.org/10.3389/fmicb.2022.914713; PMid:35794911 PMCid:PMC9251515

19. Femi-Ola TO, Oluwole OA, Olowomofe TO, Yakubu H. (2015). Isolation and screening of biosurfactant-producing bacteria from soil contaminated with domestic waste water. BJES. 3(1): 58-63.

20. Howell CA, Mikhalovsky SV, Markaryan EN, Khovanov AV. (2019). Investigation of the adsorption capacity of the enterosorbent Enterosgel for a range of bacterial toxins, bile acids and pharmaceutical drugs. Sci Rep. 9: 5629. https://doi.org/10.1038/s41598-019-42176-z; PMid:30948767 PMCid:PMC6449336

21. Jacques P. (2011). Surfactin and other lipopeptides from Bacillus spp. In Biosurfactants: From Genes to Applications, eds Soberón-Chávez G. Berlin, Heidelberg: Springer: 57-91. https://doi.org/10.1007/978-3-642-14490-5_3

22. Janek T, Łukaszewicz M, Krasowka A. (2012, Feb 23). Antiadhesive activity of the biosurfactant pseudofactin II secreted by the Arctic bacterium Pseudomonas fluorescens BD5. BMC Microbiol. 12: 24. https://doi.org/10.1186/1471-2180-12-24; PMid:22360895 PMCid:PMC3310744

23. Jemil N, Ben Ayed H, Manresa A, Nasri M, Hmidet N. (2017). Antioxidant properties, antimicrobial and anti-adhesive activities of DCS1 lipopeptides from Bacillus methylotrophicus DCS1. BMC Microbiol. 17(1): 144. https://doi.org/10.1186/s12866-017-1050-2; PMid:28659164 PMCid:PMC5490168

24. Joshi SJ, Suthar H, Yadav AK, Hingurao K, Nerurkar A. (2012, Aug 29). Occurrence of biosurfactant producing Bacillus spp. in diverse habitats. ISRN Biotechnol. 2013: 652340. https://doi.org/10.5402/2013/652340; PMid:25969778 PMCid:PMC4403617

25. Kotzampassi K. (2022). Why Give My Surgical Patients Probiotics. Nutrients. 14(20): 4389. https://doi.org/10.3390/nu14204389; PMid:36297073 PMCid:PMC9606978

26. Leistner R, Kohlmorgen B, Brodzinski A, Schwab F, Lemke E et al. (2023). Environmental cleaning to prevent hospital-acquired infections on non-intensive care units: a pragmatic, single-centre, cluster randomized controlled, crossover trial comparing soap-based, disinfection and probiotic cleaning. EClinicalMedicine. 59: 101958. https://doi.org/10.1016/j.eclinm.2023.101958; PMid:37089619 PMCid:PMC10113752

27. Lo RS, Austin AS, Freeman JG. (2014). Is there a role for probiotics in liver disease? ScientificWorldJournal. 874768. https://doi.org/10.1155/2014/874768; PMid:25436233 PMCid:PMC4243598

28. Mascena GV, Cavalcanti Melo MCS, Benevides Gadelha DN, Beserra Oliveira TK, Brandt CT. (2014). Severe autogenously fecal peritonitis in ageing Wistar rats. Response to intravenous meropenem. Acta Cirúrgica Brasileira. 29(9): 615-21. https://doi.org/10.1590/S0102-8650201400150010; PMid:25252209

29. Paster YeU, redaktor. (2005). Imunolohiia: pidruchnyk. Kyiv: Vyshcha shkola: 599.

30. Penumetcha SS, Ahluwalia S, Irfan R, Khan SA, Rohit Reddy S, Vasquez Lopez ME et al. (2021). The Efficacy of Probiotics in the Management of Helicobacter Pylori: A Systematic Review. Cureus. 13(12): e20483. eCollection 2021 Dec. PMID: 35047301. PMCID: PMC8760009. https://doi.org/10.7759/cureus.20483

31. Perova-Sharonova V. (2020). Comparison of different methods of postoperative analgesia in children with peritonitis complicated with intra-abdominal hypertension. Paediatric surgery (Ukraine). 1(66): 41-50. https://doi.org/10.15574/PS.2020.66.41

32. Persson JE, Viana P, Persson M, Relvas JH, Danielski LG. (2024). Perioperative or Postoperative Probiotics Reduce Treatment-Related Complications in Adult Colorectal Cancer Patients Undergoing Surgery: A Systematic Review and Meta-analysis. J Gastrointest Cancer. Epub ahead of print. https://doi.org/10.1007/s12029-024-01016-8; PMid:38231290

33. Polyovyy VP, Sydorchuk RI, Fedonyuk LY, Rotar OV, Polyovyy PV, Chepega IG et al. (2021). Application of antibiotics and probiotics for prevention of antibiotic-associated dysbiosis in patients with generalized peritonitis and enteral dysfunction supports staff awareness. Wiad Lek. 74; 3 cz 1: 508-511. https://doi.org/10.36740/WLek202103123; PMid:33813459

34. Ramos AM, Frantz AL. (2023). Probiotic-Based Sanitation in the Built Environment – An Alternative to Chemical Disinfectants. Appl. Microbiol. 3(2): 536-548. https://doi.org/10.3390/applmicrobiol3020038

35. Rau BM, Frigerio I, Buchler MW, Wegscheider K, Bassi C, Puolakkainen PA et al. (2007). Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: a prospective, international multicenter study. Arch Surg. 142(2): 134-142. https://doi.org/10.1001/archsurg.142.2.134; PMid:17309964

36. Rusak PS, Tolstanov OK, Kontorovich OM, Chornopishchuk NP. (2022). Microbiology of uncomplicated and destructive appendicitis in children. Paediatric Surgery (Ukraine). 3(76): 41-51. https://doi.org/10.15574/PS.2022.76.41

37. Sadekuzzaman M, Yang S, Mizan MFR, Ha SD. (2015). Current and recent advanced strategies for combating biofilms. Compr Rev Food Sci Food Saf. 14: 491-509. https://doi.org/10.1111/1541-4337.12144

38. Soffritti I, D'Accolti M, Cason C, Lanzoni L, Bisi M, Volta A et al. (2022). Introduction of Probiotic-Based Sanitation in the Emergency Ward of a Children's Hospital During the COVID-19 Pandemic. Infect Drug Resist. 15: 1399-1410. https://doi.org/10.2147/IDR.S356740; PMid:35386291 PMCid:PMC8978905

39. Stein T. (2005). Bacillus subtilis antibiotics: structures, syntheses and specific functions. Mol. Microbiol. 56(4): 845-57. https://doi.org/10.1111/j.1365-2958.2005.04587.x; PMid:15853875

40. Stone W, Tolmay J, Tucker K, Wolfaardt GM. (2020). Disinfectant, Soap or Probiotic Cleaning? Surface Microbiome Diversity and Biofilm Competitive Exclusion. Microorganisms. 8(11): 1726. https://doi.org/10.3390/microorganisms8111726; PMid:33158159 PMCid:PMC7694204

41. Tarricone R, Rognoni C, Arnoldo L, Mazzacane S, Caselli E. (2020). A Probiotic-Based Sanitation System for the Reduction of Healthcare Associated Infections and Antimicrobial Resistances: A Budget Impact Analysis. Pathogens. 9(6): 502. https://doi.org/10.3390/pathogens9060502; PMid:32585922 PMCid:PMC7350316

42. Vandini A, Temmerman R, Frabetti A, Caselli E, Antonioli P, Balboni PG et al. (2014). Hard surface biocontrol in hospitals using microbial-based cleaning products. PLoS One. 9(9): e108598. https://doi.org/10.1371/journal.pone.0108598; PMid:25259528 PMCid:PMC4178175

43. Wang X, Hu W, Zhu L, Yang Q. (2017). Bacillus subtilis and surfactin inhibit the transmissible gastroenteritis virus from entering the intestinal epithelial cells. Biosci Rep. 37(2): BSR20170082. https://doi.org/10.1042/BSR20170082; PMid:28270576 PMCid:PMC5469330

44. Wormald R, Humphreys PN, Charles CJ, Rout SP. (2023). Bacillus-based probiotic cleansers reduce the formation of dry biofilms on common hospital surfaces. Microbiologyopen. 12(6):e1391. https://doi.org/10.1002/mbo3.1391; PMid:38129979 PMCid:PMC10664183

45. Zhao Z, Li W, Tran TT, Loo SCJ. (2024). Bacillus subtilis SOM8 isolated from sesame oil meal for potential probiotic application in inhibiting human enteropathogens. BMC Microbiol. 24(1): 104. https://doi.org/10.1186/s12866-024-03263-y; PMid:38539071 PMCid:PMC11312844